Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,6-di(para-amidinophenoxy)hexane
2. 1,6-di-(4-amidinophenoxy)hexane
3. Dsomdine
4. Hexamidine
5. Hexamidine Dihydrochloride
6. Hexamidine Isethionate
7. Hexaseptine
8. Hexomdine
9. Hexomedin
10. Hexomedin N
11. Hexomedine
12. Laryngomedin N
13. Ophtamedine
1. 659-40-5
2. Desomedine
3. Hexamidine Isethionate
4. Hexomedine
5. Ophtamedine
6. Esomedina
7. Hexamidine Diisetionate
8. 023xa5z50l
9. 4-[6-(4-carbamimidoylphenoxy)hexoxy]benzenecarboximidamide;2-hydroxyethanesulfonic Acid
10. 2-hydroxyethanesulphonic Acid, Compound With 4,4'-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2:1)
11. 2535 Rp
12. Rp 2535
13. 2535 R. P.
14. Desmedine
15. 4,4'-(hexane-1,6-diylbis(oxy))dibenzimidamide Bis(2-hydroxyethanesulfonate)
16. Nsc-115848
17. Hexomedin
18. Unii-023xa5z50l
19. Hexamidin 2-hydroxyethansulfonat
20. 2-hydroxyethanesulphonic Acid, Compound With 4,4'-(hexane-1,6-diylbis(oxy))bis(benzenecarboxamidine) (2:1)
21. Einecs 211-533-5
22. Hexamidine Isetionate
23. Nsc 115848
24. 2-hydroxyethanesulphonic Acid, Compound With 4,4'-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2
25. Schembl15940090
26. Amy7835
27. Hexamidine Isethionate [mi]
28. Hexamidine Isetionate [mart.]
29. 4-[6-(4-carbamimidoylphenoxy)hexoxy]benzamidine; 2-hydroxyethanesulfonic Acid
30. Akos015896206
31. Hexamidine Isetionate [who-dd]
32. Hexamidine Diisethionate [inci]
33. Rf-2535
34. Ethanesulfonic Acid, 2-hydroxy-, Compd. With 4,4'-(hexamethylenedioxy)dibenzamidine (2:1)
35. As-83166
36. Ft-0627027
37. Hexamidine Diisetionate [ep Impurity]
38. Hexamidine Diisetionate [ep Monograph]
39. 659h405
40. A835285
41. Q27231489
42. 4,4'-(hexamethylenedioxy)dibenzamidine Isethionate
43. 4,4'-(hexane-1,6-diylbis(oxy))dibenzimidamidebis(2-hydroxyethanesulfonate)
44. 4,4'-(hexamethylenedioxy)dibenzamidine Bis(2-hydroxyethanesulphonate)
45. Ethanesulfonic Acid, 2-hydroxy-, Compd. With 4,4'-(1,6-hexanediylbis(oxy))bis(benzenecarboximidamide) (2:1)
Molecular Weight | 606.7 g/mol |
---|---|
Molecular Formula | C24H38N4O10S2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 15 |
Exact Mass | 606.20293577 g/mol |
Monoisotopic Mass | 606.20293577 g/mol |
Topological Polar Surface Area | 284 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 505 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Switzerland
Brand Name : Desomedin
Dosage Form : Gtt Opht
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Clotrimazolum; Hexamidini diisethionas
Brand Name : Imazol
Dosage Form : Cream
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Clotrimazolum; Hexamidini diisethionas; Prednisolone acetate
Brand Name : Imacort
Dosage Form : Cream
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Brand Name : Zamisept
Dosage Form : Eye drops, solution
Dosage Strength : 1mg/ml
Packaging : Multi-dose container 10 0.6ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Generic
Registration Country : Turkey
Zinc Oxide; Dexpanthenol; L-Alpha-Lecithin; Allantoin; Hexamidine
Brand Name : Minish
Dosage Form : CREAM
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Hexamidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hexamidine, including repackagers and relabelers. The FDA regulates Hexamidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hexamidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hexamidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hexamidine supplier is an individual or a company that provides Hexamidine active pharmaceutical ingredient (API) or Hexamidine finished formulations upon request. The Hexamidine suppliers may include Hexamidine API manufacturers, exporters, distributors and traders.
click here to find a list of Hexamidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hexamidine CEP of the European Pharmacopoeia monograph is often referred to as a Hexamidine Certificate of Suitability (COS). The purpose of a Hexamidine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hexamidine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hexamidine to their clients by showing that a Hexamidine CEP has been issued for it. The manufacturer submits a Hexamidine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hexamidine CEP holder for the record. Additionally, the data presented in the Hexamidine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hexamidine DMF.
A Hexamidine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hexamidine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hexamidine suppliers with CEP (COS) on PharmaCompass.
Hexamidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hexamidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hexamidine GMP manufacturer or Hexamidine GMP API supplier for your needs.
A Hexamidine CoA (Certificate of Analysis) is a formal document that attests to Hexamidine's compliance with Hexamidine specifications and serves as a tool for batch-level quality control.
Hexamidine CoA mostly includes findings from lab analyses of a specific batch. For each Hexamidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hexamidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Hexamidine EP), Hexamidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hexamidine USP).
LOOKING FOR A SUPPLIER?